Public Company News

Manulife Hong Kong and JUST FEEL Promote Emotional Well-Being with City's First "My Flag Day"

500 family volunteers distribute over 10,000 free flags to encourage the public to share their feelings HONG KONG, Oct. 18, 2025 /PRNewswire/ -- Manulife Hong Kong and JUST FEEL, a Hong Kong-based NGO dedicated to emotional education, successfully held the city's first-ever "My Flag Day" today. ...

2025-10-18 16:23 3985

Research Updates on a Phase III Clinical Trial of Anbenitamab (KN026) Presented at ESMO Congress 2025 LBA Oral Presentation Session

SUZHOU, China, Oct. 18, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology Co., Ltd., a wholl...

2025-10-18 14:59 2849

Yunji Technology Debuts on HKEX, Partners with Luxshare Precision to Accelerate Global Expansion

HONG KONG, Oct. 18, 2025 /PRNewswire/ -- Beijing Yunji Technology Co., Ltd. (the "Company"; Stock code: 2670) today announced that shares of the Company have started to be traded on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code "2670".

2025-10-18 10:12 4810

Agoda Joins as Main Sponsor of Singapore's Iconic #HuntTheMouse Cash Hunt

SINGAPORE, Oct. 18, 2025 /PRNewswire/ -- Digital travel platform Agoda has signed up as a main sponsor for the much-anticipated #HuntTheMouse cash hunt in Singapore. Running from 16 October to 14 December 2025, the event is organized by Singaporean company Sqkii and offers participants a chance to...

2025-10-18 09:19 2801

PINTEC's Subsidiary ZIITECH Makes Its Debut at Tech Week Singapore 2025

BEIJING, Oct. 17, 2025 /PRNewswire/ -- Pintec Technology Holdings Limited (Nasdaq: PT) ("PINTEC" or the "Company"), a leading technology platform committed to enabling innovative financial and digital solutions for businesses worldwide, today announced that its subsidiary ZIITECH PTY LTD ("ZIITEC...

2025-10-18 04:05 4101

CLPS Incorporation Reports Financial Results for the Second Half and Full Year of Fiscal 2025

HONG KONG, Oct. 17, 2025 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS), today announced its financial results for the six months and full year of fiscal 2025 ended June 30, 2025. During this fiscal year, we faced a significant challenge when our long-standing and hi...

2025-10-17 21:23 5876

NYSE Content Advisory: Pre-Market Update + Automakers await 5-year tariff relief extension

NEW YORK, Oct. 17, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + Automakers await 5-ye...

2025-10-17 20:55 2745

SparkRWA Expands AI Applications to Empower the Global Green Economy and Drive Sustainable Innovation

HONG KONG, Oct. 17, 2025 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), Asia's leading innovation-driven creative ecosystem, today announced an extended application of its proprietary AI technologies under theSparkRWA Green Creator Framework, marking a major step toward integrating artificial...

2025-10-17 20:43 3110

Re-imagining Neo-Pragmatic Lifestyle: EPWK Launches Strategic Upgrade with "EPWK Curated Goods"

XIAMEN, China, Oct. 17, 2025 /PRNewswire/ -- "We grew weary of life's monotony, so we embarked on a journey to find 'EPWK Curated Goods.' Each selected item must pass our stringent 'Three Goods' standard: Good-looking, Good-to-use, and Good-surprise. We believe that truly excellent products can i...

2025-10-17 20:36 2019

Kelun-Biotech's Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC

CHENGDU, China, Oct. 17, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's human epidermal growth factor receptor 2 (HER2)-directed antibody-drug conjugate (ADC) trastuzumab botidotin (also known as A166)  was approved for marketi...

2025-10-17 20:22 2562

Autoliv: Financial Report July - September 2025

STOCKHOLM, Oct. 17, 2025 /PRNewswire/ --  Q3 2025: Record 3rd quarter sales, operating income and EPS Financial highlights Q3 2025 $2,706 million net sales 5.9% net sales increase 3.9% organic sales growth* 9.9% operating margin 10.0% adjusted operating margin* $2.28 diluted EPS, 31% increase $2....

2025-10-17 20:10 2323

Minesto part of Swedish high-level delegation to South Korea

GOTHENBURG, Sweden, Oct. 17, 2025 /PRNewswire/ -- This week, leading ocean energy technology developer Minesto was part of a high-level Swedish delegation toSouth Korea aiming to explore new partnerships and strengthen bilateral collaboration in the green transition. The delegation, led by HRH Cr...

2025-10-17 20:05 1888

Erayak Power Solution Group Inc. Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy

WENZHOU, China, Oct. 17, 2025 /PRNewswire/ -- Erayak Power Solution Group Inc. ("Erayak" or the "Company") (Nasdaq: RAYA), a leading manufacturer and exporter of advanced power solution products, today announced the establishment of its U.S. subsidiary, Nexora Group Inc., marking a strategic mile...

2025-10-17 18:16 3613

KFin Technologies acquires 51% controlling stake in Ascent Fund Services for USD 35 million, expanding into the global fund administration industry

MUMBAI, India, Oct. 17, 2025 /PRNewswire/ -- KFin Technologies Limited  ("KFintech") (BSE: 543720) (NSE: KFINTECH), a leading provider of investor and issuer solutions, has completed the acquisition of a 51% controlling stake in Ascent Fund Services (Singapore) Pte. Lt...

2025-10-17 17:39 3474

SEMIFIVE Submits Securities Registration for KOSDAQ Listing

* Secures Only 'One-Stop AI ASIC Solution' in Korea and Big-Die Design Capability * 2025 Q3 Cumulative Revenue Expected to Surpass KRW 90 Billion; Large AI Chip Mass Production Begins, Growth to Accelerate from Q4 * Wins Successive AI Chip Design Projects for Global Customers, Expanding int...

2025-10-17 17:25 3591

NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. TO HOLD ANNUAL GENERAL MEETING ON NOVEMBER 21, 2025

BEIJING, Oct. 17, 2025 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU and SEHK: 9901), a provider of private educational services inChina, today announced that it will hold an annual general meeting (the "AGM") of shareholders (the "Not...

2025-10-17 17:00 2731

I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences

* New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for patients worldwide * Intention to pursue a Hong Kong initial public offering (IPO) to expand ...

2025-10-17 15:21 4647

RAVEN2, NETMARBLE'S BRUTAL DARK FANTASY MMORPG, ENTERS FINAL COUNTDOWN TO GLOBAL LAUNCH

SEOUL, South Korea, Oct. 17, 2025 /PRNewswire/ -- Netmarble, a renowned developer and publisher of high-quality games, is gearing up for the global launch of its ultimate dark fantasy MMORPGRaven2, which will officially launch onOctober 22 at 1AM (UTC) for both mobile and PC platforms. Pre-downlo...

2025-10-17 15:00 3343

KLN Wins GBA Excellence in Logistics Solutions Award at the Hong Kong Economic Journal GBA Brand Awards of Excellence 2025

HONG KONG, Oct. 17, 2025 /PRNewswire/ -- KLN Logistics Group Limited ("KLN"; Stock Code 0636.HK) has won the title of GBA Excellence in Logistics Solutions Award at the Hong Kong Economic Journal GBA Brand Awards of Excellence 2025 (the 'Awards'), recognised for its forward-looking strategic deve...

2025-10-17 13:34 1767

FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States

* YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications – adolescent hidradenitis suppurativa (HS) and pediatric uveitis (UV), in the U.S.[1],[2] * Pediatric UV is a rare eye inflammation in children, representing 5–10% of all uveitis...

2025-10-17 13:32 3877